THE PROGNOSTIC IMPACT OF A NEGATIVE CONFIRMATORY BIOPSY IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER

被引：0
|
作者：
Salari, Keyan
Zlatev, Dimitar
Kuppermann, David
Preston, Mark
Dahl, Douglas
Efstathiou, Jason
Blute, Michael
Zietman, Anthony
Feldman, Adam
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP17-14
引用
收藏
页码：E210 / E210
页数：1
相关论文
共 50 条
  • [21] Risk of progression following a negative biopsy in prostate cancer active surveillance
    Beckmann, Kerri
    Santaolalla, Aida
    Sugimoto, Mikio
    Carroll, Peter
    Rubio, Jose
    Villers, Arnauld
    Bjartell, Anders
    Morgan, Todd
    Dasgupta, Prokar
    Van Hemelrijck, Mieke
    Elhage, Oussama
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (02) : 403 - 409
  • [22] Comparing confirmatory biopsy outcomes between MRI-targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillance
    Shapiro, Daniel D.
    Gregg, Justin R.
    Lim, Amy H.
    Nogueras-Gonzalez, Graciela M.
    Choi, Haesun
    Kang, Hyunseon C.
    Inguillo, Irene A.
    Chapin, Brian F.
    Davis, John W.
    Ward, John F.
    BJU INTERNATIONAL, 2021, 127 (03) : 340 - 348
  • [23] Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer
    L-M Wong
    S Ferrara
    S M H Alibhai
    A Evans
    T Van der Kwast
    G Trottier
    N Timilshina
    A Toi
    G Kulkarni
    R Hamilton
    A Zlotta
    N Fleshner
    A Finelli
    Prostate Cancer and Prostatic Diseases, 2015, 18 : 69 - 74
  • [24] NECESSITY OF CONFIRMATORY PROSTATE BIOPSY TO INSURE ACCURATE ELIGIBILITY FOR ACTIVE SURVEILLANCE
    Motamedinia, Piruz
    RiChard, Jamie
    Hruby, Greg
    DeCastro, G. Joel
    Benson, Mitchell
    JOURNAL OF UROLOGY, 2012, 187 (04): : E888 - E888
  • [25] Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer
    Wong, L-M
    Ferrara, S.
    Alibhai, S. M. H.
    Evans, A.
    Van der Kwast, T.
    Trottier, G.
    Timilshina, N.
    Toi, A.
    Kulkarni, G.
    Hamilton, R.
    Zlotta, A.
    Fleshner, N.
    Finelli, A.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2015, 18 (01) : 69 - 74
  • [26] Magnetic Resonance Imaging-Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer
    Jayadevan, Rajiv
    Felker, Ely R.
    Kwan, Lorna
    Barsa, Danielle E.
    Zhang, Haoyue
    Sisk, Anthony E.
    Delfin, Merdie
    Marks, Leonard S.
    JAMA NETWORK OPEN, 2019, 2 (09)
  • [27] MODELS INTEGRATING MRI PREDICT PROSTATE CANCER UPGRADING ON CONFIRMATORY BIOPSY IN ACTIVE SURVEILLANCE PATIENTS
    Barashi, Nimrod S.
    Golan, Shay
    Wang, Chi
    Hirschhorn, Kimberly
    Petkewicz, Jacqueline
    Silvers, Robert
    Thakrar, Kiran
    Eggener, Scott E.
    Helfand, Brian T.
    JOURNAL OF UROLOGY, 2018, 199 (04): : E141 - E141
  • [28] The importance of confirmatory biopsy in patients under active surveillance for prostate cance
    Galloway, Peter
    Heywood, Sean
    Chong, Peter
    Blatt, Alison
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 148 - 148
  • [29] Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance?
    Satasivam, Prassannah
    Poon, Bing Ying
    Ehdaie, Behfar
    Vickers, Andrew J.
    Eastham, James A.
    JOURNAL OF UROLOGY, 2016, 195 (01): : 74 - 79
  • [30] Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy EDITORIAL COMMENT
    Glaser, Zachary A.
    Rais-Bahrami, Soroush
    JOURNAL OF UROLOGY, 2019, 201 (01): : 90 - 90
12345